Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10 | $13 | $9 | $13 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $3 | $3 | $2 | $2 |
| Enterprise Value | $13 | $15 | $11 | $15 |
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 10.4% | 19.9% | 17.9% | – |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 69.5% | 70.5% | 68.3% | 74% |
| EBITDA | -$1 | $0 | -$0 | -$1 |
| % Margin | -28.6% | 1.2% | -20.2% | -36.7% |
| Net Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | -37.3% | -8.2% | -29.9% | -33.7% |
| EPS Diluted | -5.59 | -1.13 | -3.54 | -3.48 |
| % Growth | -394.7% | 68.1% | -1.7% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |